September 7, 2022
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Fresh Tracks Therapeutics, Inc.
Registration Statement on Form S-1
File Number 333-267254
Ladies and Gentlemen:
Fresh Tracks Therapeutics, Inc. (the “Company”) hereby requests that the effectiveness of the above-referenced registration statement on Form S-1 be accelerated so that it will become effective at 4:00 p.m. Eastern time on September 9, 2022, or as soon thereafter as practicable.
Please telephone the undersigned (720-505-4755) or Jonathan R. Zimmerman of Faegre Drinker Biddle & Reath LLP (612-766-8419) if you have any questions with respect to the foregoing.
| | | | | | | | | | | |
|
| | | |
| | Very truly yours, | |
| | FRESH TRACKS THERAPEUTICS, INC. | |
| | | |
| | By: | /s/ Robert B. Brown | |
| | | Name: Robert B. Brown | |
| | | Title: Chief Executive Officer | |
